The FDA maintains a list of approved new drug application (NDA) drug products that are no longer protected by patents or exclusivities, and for which the FDA has not approved an ANDA referencing that NDA drug product.
Similar Posts
Medi-Fare Drug Pharmaceutical Compounding LLC. Blacksburg, SC. 483 issued 06/06/2025
Task Description Request Please post to the OII FOIA Electronic Reading Room
Record Date 06/06/2025
Short Title (70 char) Medi-Fare Drug Pharmaceutical Compounding LLC. Blacksburg, SC. 483 issued 06/06/2025
FEI Number 3009925820
Firm Name Medi-Fare Drug Pharmaceutical Compounding LLC
Record Type 483Central Admixture Pharmacy Services Inc. Allentown, PA. 483 issued 09/05/2025
Task Description Request Please post to the OII FOIA Electronic Reading Room
Record Date 09/05/2025
Short Title (70 char) Central Admixture Pharmacy Services Inc. Allentown, PA. 483 issued 09/05/2025
FEI Number 3009590582
Firm Name Central Admixture Pharmacy Services Inc
Record Type 483
State PA
EstDevalingam Mahalingam, M.D., Ph.D. – 721145 – 12/11/2025
Clinical InvestigatorState Importation Program Enhancements
FDA is committed to continuing to work with states and Indian tribes that seek to develop an importation proposal under section 804 of the Federal Food, Drug and Cosmetic Act.Fran’s Chocolates, LTD. Issues Allergy Alert on Undeclared Hazelnuts in Fran’s Pure Bar AlmondMilk Chocolate 46% Madagascar Plant-Based Product
December 20, 2025, Fran’s Chocolates, Ltd. of Seattle, WA is recalling 112 units of Fran’s Pure Bar Almondmilk Chocolate 46% Madagascar Plant-Based, net wt. 1.1oz, because it contains undeclared hazelnut. People who have an allergy or severe sensitivity to hazelnut run the risk of serious or life-th